Is MEDIF or NOBL a better dividend investment in 2026?

MEDIF currently yields 4345.46% with a 5% 5-year dividend growth rate. NOBL yields 2.14% with 5% growth. The better choice depends on your goal: MEDIF offers higher current income.

What is the dividend yield difference between MEDIF and NOBL?

MEDIF has a forward dividend yield of 4345.46% ($2.00/share annually). NOBL yields 2.14% ($2.27/share annually). The yield gap is 4343.32 percentage points.

Home › Compare › MEDIF vs NOBL

MEDIF vs NOBL: Dividend Comparison 2026

MEDIF yields 4345.46% · NOBL yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MEDIF wins by $15969693446288.77M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MEDIF

● Live price

4345.46%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$15969693446288.79M

Annual income

$15,278,069,441,942,714,000.00

Full MEDIF calculator →

NOBL

● Live price

2.14%

Share price

$106.01

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.8K

Annual income

$246.19

Full NOBL calculator →

Portfolio growth — MEDIF vs NOBL

📍 MEDIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MEDIF	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MEDIF + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MEDIF pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDIF

Annual income on $10K today (after 15% tax)

$369,364.48/yr

After 10yr DRIP, annual income (after tax)

$12,986,359,025,651,306,000.00/yr

NOBL

Annual income on $10K today (after 15% tax)

$182.19/yr

After 10yr DRIP, annual income (after tax)

$209.26/yr

At 15% tax rate, MEDIF beats the other by $12,986,359,025,651,306,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDIF + NOBL for your $10,000?

MEDIF: 50%NOBL: 50%

100% NOBL50/50100% MEDIF

Portfolio after 10yr

$7984846723144.41M

Annual income

$7,639,034,720,971,357,000.00/yr

Blended yield

95.67%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDIF buys

NOBL buys

No recent congressional trades found for MEDIF or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMEDIFNOBL

Forward yield	4345.46% ✓	2.14%
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$15969693446288.79M ✓	$22.8K
Annual income after 10y	$15,278,069,441,942,714,000.00 ✓	$246.19
Total dividends collected	$15922667488789.34M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MEDIF vs NOBL ($10,000, DRIP)

Year	MEDIF Portfolio	MEDIF Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$445,246	$434,546.44	$10,914	$214.34	+$434.3K → MEDIF
2	$18,558,681	$18,082,267.04	$11,897	$218.63	+$18.55M → MEDIF
3	$724,251,944	$704,394,155.22	$12,952	$222.72	+$724.24M → MEDIF
4	$26,465,566,588	$25,690,617,008.13	$14,086	$226.62	+$26465.55M → MEDIF
5	$905,687,152,836	$877,368,996,586.58	$15,302	$230.33	+$905687.14M → MEDIF
6	$29,029,592,495,582	$28,060,507,242,048.22	$16,607	$233.85	+$29029592.48M → MEDIF
7	$871,632,797,918,927	$840,571,133,948,653.80	$18,007	$237.18	+$871632797.90M → MEDIF
8	$24,520,223,407,609,444	$23,587,576,313,836,190.00	$19,508	$240.35	+$24520223407.59M → MEDIF
9	$646,377,574,155,211,500	$620,140,935,109,069,400.00	$21,116	$243.35	+$646377574155.19M → MEDIF
10	$15,969,693,446,288,792,000	$15,278,069,441,942,714,000.00	$22,841	$246.19	+$15969693446288.77M → MEDIF

MEDIF vs NOBL: Complete Analysis 2026

MEDIF — Stock

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Full MEDIF Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this MEDIF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDIF vs SCHD MEDIF vs JEPI MEDIF vs O MEDIF vs KO MEDIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.